Scandinavian ChemoTech AB nominated for the Swecare Export Awards
We are proud and honoured to announce that we once again have been nominated to the Swecare Export Awards – Rising Star.
The winner will be announced by the Secretary of State, Tobias Lundin Gerdås, at Swecare’s annual conference April 28th 2022.
This year’s jury consists of Niclas Jacobson, Government Offices and Ministry of Social Affairs, Anders Blanck, Lif - the researching pharmaceutical companies, Anna Lefevre Skjöldebrand, Swedish Medtech and last year’s “Rising Star” winner Johan Gustafsson, Visiba Care.
We humbly thank you for the nomination!
For further information please contact: Mohan Frick, CEO
+46 (0)10-218 93 00
info@chemotech.se
Certified Adviser: Erik Penser Bank, Tel: +46 8 463 80 00, E-mail: certifiedadviser@penser.se
Scandinavian ChemoTech AB (publ)
ChemoTech is a Swedish medical technology company based in Lund that has developed a patented technology platform to offer cancer patients access to a new treatment alternative, Tumour Specific Electroporation (TSE™), available for treatment of both humans and animals. There are a large number of cancer patients whose tumours for various reasons cannot be treated by conventional methods but where TSE can be a solution. Therefore, the company continuously evaluates new opportunities and areas of application for the technology. ChemoTech's shares (CMOTEC B) are listed on Nasdaq First North Growth Market in Stockholm and Erik Penser Bank is the company's Certified Adviser. Read more at: www.chemotech.se.
